Safety and Efficacy of Anti–IL-23 Monoclonal Antibody QX004N for Patients With Psoriasis

Authors

De‐Ming Yang (ORCID: https://orcid.org/0000-0002-6923-4855)
Cuiyun Li (ORCID: https://orcid.org/0000-0002-6306-2394)
Meng Wang (ORCID: https://orcid.org/0000-0002-5860-7206)
Jingrui Liu (ORCID: https://orcid.org/0009-0004-2663-6485)
Yanhua Ding (ORCID: https://orcid.org/0009-0005-4648-4797)
Shanshan Li (ORCID: https://orcid.org/0000-0002-7646-3680)
Qianqian Li (ORCID: https://orcid.org/0000-0001-6961-771X)
Bing Li (ORCID: https://orcid.org/0000-0001-8958-2972)
Xiaoxue Zhu (ORCID: https://orcid.org/0009-0006-7718-1649)
Hong Zhang (ORCID: https://orcid.org/0000-0002-4392-7370)
Xiaojiao Li (ORCID: https://orcid.org/0000-0002-2936-7864)
Min Wu (ORCID: https://orcid.org/0000-0002-4784-226X)
Min Fang (ORCID: https://orcid.org/0000-0002-7910-9169)
Nan Wang (ORCID: https://orcid.org/0000-0002-8842-3424)